Advanced Search

Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2003 June;45(2) > Panminerva Medica 2003 June;45(2):99-107



A Journal on Internal Medicine

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

Frequency: Quarterly

ISSN 0031-0808

Online ISSN 1827-1898


Panminerva Medica 2003 June;45(2):99-107


ω-3 polyunsatured fatty acids role in postmyocardial infarction therapy

Imazio M., Forno D., Quaglia C., Trinchero R.

Cardiology Department, Maria Vittoria Hospital, Turin, Italy

Largely initiated by studies among Eskimos in the early 1970s, great attention has been given to possible effects of ω-3 polyunsatured fatty acids (PUFA) in cardiovacular diseases. A series of positive effects on pathogenetic mechanisms of cardiovascular disease has been discovered from laboratory studies in cell cultures, animal models and in humans. ω-3 PUFA can reduce platelets and leucocytes activities as well as plasma triglycerides. Moreover they can have antiarrhythmic properties. Nowadays patients who experienced myocardial infarction have decreased risk of total and cardiovascular mortality by treatment with ω-3 PUFA (1 g daily). This effect is present irrespective of high or low fish intake or simultaneous intake of other drugs for secondary prevention of coronary heart disease. Mainly on the basis of GISSI Prevention trial results, dietary supplementation with ω-3 PUFA is now recommended as a new component of secondary prevention after myocardial infarction in national and international guidelines.

language: English


top of page